Related content

Radionuclide therapy in oncology: the dawning of its concomitant use with other modalities?

By Valdés Olmos Renato   Hoefnagel Cornelis  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 7, 2004-07 ,pp. : 929-931

Springer Publishing Company

Access to resources Recommend Favorite

Skin dose rate conversion factors after contamination with radiopharmaceuticals: influence of contamination area, epidermal thickness and percutaneous absorption

By Covens P.   Berus D.   Caveliers V.   Struelens L.   Vanhavere F.   Verellen D.  

Journal of Radiological Protection, Vol. 33, Iss. 2, 2013-06 ,pp. : 381-393

IOP Publishing

Access to resources Recommend Favorite

CT-guided high dose rate brachytherapy ablation of liver metastases

By Collettini Federico   Gebauer Bernhard  

Imaging in Medicine, Vol. 5, Iss. 4, 2013-08 ,pp. : 383-388

Future Medicine

Access to resources Recommend Favorite

Dosimetric perturbations of a lead shield for surface and interstitial high-dose-rate brachytherapy

By Candela-Juan Cristian   Granero Domingo   Vijande Javier   Ballester Facundo   Perez-Calatayud Jose   Rivard Mark J  

Journal of Radiological Protection, Vol. 34, Iss. 2, 2014-06 ,pp. : 297-311

IOP Publishing

Access to resources Recommend Favorite

Radionuclide reporter gene imaging for cardiac gene therapy

By Inubushi Masayuki   Tamaki Nagara  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 1, 2007-06 ,pp. : 27-33

Springer Publishing Company

Access to resources Recommend Favorite